Literature DB >> 26220478

Development and applications of single-cycle infectious influenza A virus (sciIAV).

Aitor Nogales1, Steven F Baker1, William Domm1, Luis Martínez-Sobrido2.   

Abstract

The diverse host range, high transmissibility, and rapid evolution of influenza A viruses justify the importance of containing pathogenic viruses studied in the laboratory. Other than physically or mechanically changing influenza A virus containment procedures, modifying the virus to only replicate for a single round of infection similarly ensures safety and consequently decreases the level of biosafety containment required to study highly pathogenic members in the virus family. This biological containment is more ideal because it is less apt to computer, machine, or human error. With many necessary proteins that can be deleted, generation of single-cycle infectious influenza A viruses (sciIAV) can be achieved using a variety of approaches. Here, we review the recent burst in sciIAV generation and summarize the applications and findings on this important human pathogen using biocontained viral mimics.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Influenza HA-expressing MDCK cells (MDCK-HA); Influenza vaccine; Reporter virus; Reverse genetics; Single-cycle virus; Viral vectors

Mesh:

Substances:

Year:  2015        PMID: 26220478      PMCID: PMC4728073          DOI: 10.1016/j.virusres.2015.07.013

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  172 in total

1.  A replication-incompetent PB2-knockout influenza A virus vaccine vector.

Authors:  Sylvia T Victor; Shinji Watanabe; Hiroaki Katsura; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects.

Authors:  J J Treanor; R F Betts
Journal:  Vaccine       Date:  1998-11       Impact factor: 3.641

4.  Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.

Authors:  Jesse D Bloom; Lizhi Ian Gong; David Baltimore
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

5.  Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.

Authors:  R B Belshe; W C Gruber; P M Mendelman; H B Mehta; K Mahmood; K Reisinger; J Treanor; K Zangwill; F G Hayden; D I Bernstein; K Kotloff; J King; P A Piedra; S L Block; L Yan; M Wolff
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

Review 6.  Immunity to respiratory viruses.

Authors:  Jacob E Kohlmeier; David L Woodland
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

7.  Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging.

Authors:  Glenn A Marsh; Raúl Rabadán; Arnold J Levine; Peter Palese
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

8.  Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity.

Authors:  G N Rogers; J C Paulson; R S Daniels; J J Skehel; I A Wilson; D C Wiley
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

9.  Identification of small molecules that interfere with H1N1 influenza A viral replication.

Authors:  Angel Bottini; Surya K De; Bas J G Baaten; Bainan Wu; Elisa Barile; Stephen Soonthornvacharin; John L Stebbins; Linda M Bradley; Sumit K Chanda; Maurizio Pellecchia
Journal:  ChemMedChem       Date:  2012-11-08       Impact factor: 3.466

Review 10.  Viral membrane fusion.

Authors:  Stephen C Harrison
Journal:  Virology       Date:  2015-04-10       Impact factor: 3.616

View more
  22 in total

1.  Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.

Authors:  Venice Du Pont; Christoph Wirblich; Jeong-Joong Yoon; Robert M Cox; Matthias J Schnell; Richard K Plemper
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Engineered influenza virions reveal the contributions of non-hemagglutinin structural proteins to vaccine mediated protection.

Authors:  Zhaochen Luo; Alanson W Girton; Brook E Heaton; Nicholas S Heaton
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

Review 3.  Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.

Authors:  Annette Fox; Kylie M Quinn; Kanta Subbarao
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

4.  Crowd on a Chip: Label-Free Human Monoclonal Antibody Arrays for Serotyping Influenza.

Authors:  Hanyuan Zhang; Carole Henry; Christopher S Anderson; Aitor Nogales; Marta L DeDiego; Joseph Bucukovski; Luis Martinez-Sobrido; Patrick C Wilson; David J Topham; Benjamin L Miller
Journal:  Anal Chem       Date:  2018-07-20       Impact factor: 6.986

Review 5.  Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses.

Authors:  Venice Du Pont; Richard K Plemper; Matthias J Schnell
Journal:  Curr Opin Virol       Date:  2019-02-10       Impact factor: 7.090

6.  Oxygen-dependent changes in lung development do not affect epithelial infection with influenza A virus.

Authors:  William Domm; Min Yee; Ravi S Misra; Robert Gelein; Aitor Nogales; Luis Martinez-Sobrido; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-10       Impact factor: 5.464

7.  A Novel Fluorescent and Bioluminescent Bireporter Influenza A Virus To Evaluate Viral Infections.

Authors:  Aitor Nogales; Gines Ávila-Pérez; Javier Rangel-Moreno; Kevin Chiem; Marta L DeDiego; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

8.  A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.

Authors:  Xingui Tian; Shelby Landreth; Yao Lu; Kannupriya Pandey; Yan Zhou
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

9.  Generation and Characterization of Single-Cycle Infectious Canine Influenza A Virus (sciCIV) and Its Use as Vaccine Platform.

Authors:  Aitor Nogales; Kevin Chiem; Michael Breen; Marta L DeDiego; Colin R Parrish; Luis Martínez-Sobrido
Journal:  Methods Mol Biol       Date:  2022

Review 10.  Replication-Competent Influenza A Viruses Expressing Reporter Genes.

Authors:  Michael Breen; Aitor Nogales; Steven F Baker; Luis Martínez-Sobrido
Journal:  Viruses       Date:  2016-06-23       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.